CTNNB1 and colorectal cancer: Previous studies discovered deubiquitinase and acetyltransferase properties of AvrA leading to upregulation of the beta-catenin signaling pathway and modifying p53 activities [14, 15, 18], which are critical in initiation and progression of colorectal cancer.